Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Integrin 9β1 is a receptor for nerve growth factor and other neurotrophins
Izabela Staniszewska1,
Ilker K. Sariyer1,
Shimon Lecht2,
Meghan C. Brown1,
Erin M. Walsh1,
George P. Tuszynski1,
Mahmut Safak1,
Philip Lazarovici2, and
Cezary Marcinkiewicz1,*
1 Department of Neuroscience, Center for Neurovirology and Cancer Biology, Temple University, School of Medicine, Philadelphia, PA 19122, USA 2 Department of Pharmacology and Experimental Therapeutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, School of Pharmacy, Jerusalem 91120, Israel
* Author for correspondence (e-mail: cmarcink{at}temple.edu)
Accepted for publication 8 November 2007.
Abstract:
The integrin 9β1 is a multifunctional receptor that interactswith a variety of ligands including vascular cell adhesion molecule1, tenascin C and osteopontin. We found that this integrin isa receptor for nerve growth factor (NGF) and two other neurotrophins,brain-derived neurotrophic factor and NT3, using a cell adhesionassay with the 9SW480 cell line. Interaction of 9β1 withNGF was confirmed in an ELISA assay by direct binding to purifiedintegrin. 9β1 integrin binds to neurotrophins in a mannersimilar to another common neurotrophin receptor, p75NTR (NGFR),although 9β1 activity is correlated with induction of pro-survivaland pro-proliferative signaling cascades. This property of 9β1resembles the interaction of NGF with a high affinity receptor,TrkA, however, this integrin shows a low affinity for NGF. NGFinduces chemotaxis of cells expressing 9β1 and their proliferation.Moreover, 9β1 integrin is a signaling receptor for NGF,which activates the MAPK (Erk1/2) pathway. The 9β1-dependentchemotactic ability of NGF appears to result from the activationof paxillin.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Nancy R. Gough (19 February 2008) Sci. Signal.1 (7), ec62.
[DOI: 10.1126/stke.17ec62] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Polydom/SVEP1 Is a Ligand for Integrin {alpha}9{beta}1.
R. Sato-Nishiuchi, I. Nakano, A. Ozawa, Y. Sato, M. Takeichi, D. Kiyozumi, K. Yamazaki, T. Yasunaga, S. Futaki, and K. Sekiguchi (2012)
J. Biol. Chem.
287, 25615-25630
|Abstract »|Full Text »|PDF »
Importance of interaction between nerve growth factor and {alpha}9{beta}1 integrin in glial tumor angiogenesis.
E. M. Walsh, R. Kim, L. Del Valle, M. Weaver, J. Sheffield, P. Lazarovici, and C. Marcinkiewicz (2012)
Neuro Oncology
14, 890-901
|Abstract »|Full Text »|PDF »
Matrix Metalloproteinase-9 Regulates Survival of Neurons in Newborn Hippocampus.
Vascular Endothelial Growth Factor A (VEGF-A) Induces Endothelial and Cancer Cell Migration through Direct Binding to Integrin {alpha}9{beta}1: IDENTIFICATION OF A SPECIFIC {alpha}9{beta}1 BINDING SITE.
S. Oommen, S. K. Gupta, and N. E. Vlahakis (2011)
J. Biol. Chem.
286, 1083-1092
|Abstract »|Full Text »|PDF »
Integrin {alpha}9{beta}1 mediates enhanced cell migration through nitric oxide synthase activity regulated by Src tyrosine kinase.
{alpha}9 Integrin Promotes Neurite Outgrowth on Tenascin-C and Enhances Sensory Axon Regeneration.
M. R. Andrews, S. Czvitkovich, E. Dassie, C. F. Vogelaar, A. Faissner, B. Blits, F. H. Gage, C. ffrench-Constant, and J. W. Fawcett (2009)
J. Neurosci.
29, 5546-5557
|Abstract »|Full Text »|PDF »
Regulatory effect of nerve growth factor in {alpha}9{beta}1 integrin-dependent progression of glioblastoma.
M. C. Brown, I. Staniszewska, P. Lazarovici, G. P. Tuszynski, L. Del Valle, and C. Marcinkiewicz (2008)
Neuro Oncology
10, 968-980
|Abstract »|Full Text »|PDF »
The integrin {alpha}9{beta} 1 is a receptor for nerve growth factor and other neurotrophins.
I. Staniszewska, I. K. Sariyer, S. Lecht, M. C. Brown, E. M. Walsh, G. P. Tuszynski, M. Safak, P. Lazarovici, and C. Marcinkiewicz (2008)
Development
135, e1
|Full Text »